MedPanel

Meaningful Change in Alzheimer’s Agitation

admin — Thu, 11 Jun 2026 01:31:04 +0000

PHARMACEUTICAL · NEUROSCIENCE Case study · Recruitment & qualitative research Recruiting the experts behind clinically meaningful change in Alzheimer’s agitation MedPanel sourced and screened a specialist panel of physicians and professional caregivers for a peer-reviewed qualitative study on the Cohen-Mansfield Agitation Inventory (CMAI). Agitation is one of the most burdensome

The post Meaningful Change in Alzheimer’s Agitation appeared first on MedPanel.

Rare Disease Patient Advocacy Group Research

admin — Wed, 27 May 2026 12:04:16 +0000

Why Patient Advocacy Partnerships Matter in Rare Disease Research For pharmaceutical and biotechnology companies, the success of any rare disease program—from clinical development to commercial launch—is inextricably linked to the patient community. Indeed, Patient Advocacy Groups (PAGs) are not merely stakeholders; they are the gatekeepers of access, the custodians of

The post Rare Disease Patient Advocacy Group Research appeared first on MedPanel.

Rare Disease Research for CROs

admin — Wed, 27 May 2026 11:45:00 +0000

The Role of CROs in Rare Disease Clinical Research In rare disease research, Contract Research Organizations (CROs) play a pivotal role in the clinical development landscape. Moreover, they provide the infrastructure, expertise, and operational support necessary to conduct complex clinical trials. As a result, sponsors can reach small, geographically dispersed

The post Rare Disease Research for CROs appeared first on MedPanel.

Rare Disease Market Research

admin — Wed, 27 May 2026 04:33:10 +0000

Uncategorized — May 6, 2026 What Is Rare Disease Market Research? Rare disease market research systematically gathers clinical, economic, and patient-centered evidence from verified rare disease specialists, patients, and caregivers. Teams use these insights to shape drug development, regulatory strategy, market access, and commercial planning. For a program overview, see

The post Rare Disease Market Research appeared first on MedPanel.

MedPanel Insights Physician Research

admin — Wed, 06 May 2026 06:18:44 +0000

Introduction Physician recruitment for market research is one of the most critical and challenging aspects of healthcare insights. Physicians are the most analyzed group in healthcare market research and, at the same time, the most difficult to recruit. They have the highest incentive demands, the lowest response rates, and the

The post MedPanel Insights Physician Research appeared first on MedPanel.

MedPanel Insights Research Methodology

admin — Wed, 06 May 2026 05:54:49 +0000

Introduction You scoped the study carefully. Your incidence estimate came from a published research paper. In addition, your medical affairs team reviewed the screener. As a result, the fieldwork kicked off on schedule. However, three weeks later you have completed only 4 of 30 target interviews — and you suspect

The post MedPanel Insights Research Methodology appeared first on MedPanel.

MedPanel Insights Rare Disease

admin — Wed, 06 May 2026 04:49:38 +0000

Introduction Recruiting rare disease patients for market research sounds straightforward until you try it. A condition affecting fewer than 200,000 people nationally may have no organized patient community, unreliable diagnosis rates, and a population scattered across dozens of specialist centers — none of which makes for an easy screener call.

The post MedPanel Insights Rare Disease appeared first on MedPanel.

Informing HEOR Models with Primary Market Research in Rare Diseases

admin — Mon, 19 Jan 2026 08:12:03 +0000

HEOR models are only as credible as the inputs behind them. In rare diseases, those inputs are frequently incomplete: natural history is poorly characterized, endpoints are inconsistent, and small, fragmented patient populations amplify uncertainty in both clinical and economic parameters (Grand et
al., 2024; Pearson et al., 2018).

The post Informing HEOR Models with Primary Market Research in Rare Diseases appeared first on MedPanel.

Primary Market Research Illuminates Endpoints in Rare Disease RWE

admin — Wed, 12 Nov 2025 18:29:53 +0000

Real-world evidence (RWE) underpins modern health economics and outcomes research (HEOR), especially when traditional clinical trials are infeasible in rare diseases. Small patient populations, varying symptoms, and uncertain etiology can limit trial insight and complicate endpoint selection.

The post Primary Market Research Illuminates Endpoints in Rare Disease RWE appeared first on MedPanel.

MedPanel Insights: Challenges in Treating Rare Disease Patients

admin — Mon, 29 Apr 2019 10:59:19 +0000

100 rare disease treaters in the US and the UK shared their biggest challenges in treating and managing rare disease patients.

The post MedPanel Insights: Challenges in Treating Rare Disease Patients appeared first on MedPanel.